Pentair (NYSE:PNR) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Pentair (NYSE:PNR – Free Report) from a hold rating to a buy rating in a research note issued to investors on Sunday morning. PNR has been the subject of several other research reports. Citigroup upped their price objective on shares of Pentair from $126.00 to $133.00 and gave the […]
Entergy (NYSE:ETR) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Entergy (NYSE:ETR – Free Report) from a sell rating to a hold rating in a research report sent to investors on Sunday morning. ETR has been the subject of a number of other reports. Mizuho increased their price target on Entergy from $97.00 to $104.00 and gave the company […]
Arcus Biosciences (NYSE:RCUS) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Arcus Biosciences (NYSE:RCUS – Free Report) from a sell rating to a hold rating in a research note issued to investors on Sunday. Several other research firms have also recently weighed in on RCUS. Bank of America raised their price objective on shares of Arcus Biosciences from $17.00 to […]
VTEX (NYSE:VTEX) Cut to “Buy” at Wall Street Zen
Wall Street Zen lowered shares of VTEX (NYSE:VTEX – Free Report) from a strong-buy rating to a buy rating in a report published on Sunday. Other equities analysts have also issued reports about the stock. UBS Group reduced their target price on shares of VTEX from $10.00 to $8.00 and set a “buy” rating on […]
Wall Street Zen Downgrades Fortuna Mining (NYSE:FSM) to Hold
Fortuna Mining (NYSE:FSM – Get Free Report) (TSE:FVI) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Monday. FSM has been the topic of several other reports. Weiss Ratings reiterated a “buy (b)” rating on shares of Fortuna Mining in […]
Theravance Biopharma (NASDAQ:TBPH) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Sunday morning. TBPH has been the subject of several other research reports. HC Wainwright lifted their price objective on Theravance Biopharma from $15.00 to $20.00 and gave […]
KANZHUN (NASDAQ:BZ) Rating Lowered to Hold at Wall Street Zen
KANZHUN (NASDAQ:BZ – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Monday. BZ has been the subject of a number of other reports. The Goldman Sachs Group reaffirmed a “buy” rating on shares of KANZHUN in a […]
Levi Strauss & Co. (NYSE:LEVI) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Levi Strauss & Co. (NYSE:LEVI – Free Report) from a hold rating to a buy rating in a research report report published on Sunday morning. A number of other equities research analysts have also recently weighed in on the stock. Citigroup upped their price objective on shares of Levi […]
ESS Tech (NYSE:GWH) Cut to Sell at Wall Street Zen
Wall Street Zen cut shares of ESS Tech (NYSE:GWH – Free Report) from a hold rating to a sell rating in a research report report published on Sunday. A number of other research firms have also weighed in on GWH. Weiss Ratings reissued a “sell (d-)” rating on shares of ESS Tech in a research […]
Smith & Nephew SNATS (NYSE:SNN) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Smith & Nephew SNATS (NYSE:SNN – Free Report) from a buy rating to a strong-buy rating in a research report released on Sunday morning. A number of other equities analysts have also commented on SNN. Canaccord Genuity Group reduced their price objective on Smith & Nephew SNATS from $36.00 […]
ALX Oncology (NASDAQ:ALXO) Cut to “Sell” at Wall Street Zen
Wall Street Zen cut shares of ALX Oncology (NASDAQ:ALXO – Free Report) from a hold rating to a sell rating in a research report report published on Sunday morning. A number of other equities analysts also recently weighed in on the stock. Jefferies Financial Group initiated coverage on shares of ALX Oncology in a report […]
Motorcar Parts of America (NASDAQ:MPAA) Cut to “Buy” at Wall Street Zen
Wall Street Zen lowered shares of Motorcar Parts of America (NASDAQ:MPAA – Free Report) from a strong-buy rating to a buy rating in a report issued on Sunday morning. Other research analysts also recently issued reports about the stock. Zacks Research downgraded shares of Motorcar Parts of America from a “hold” rating to a “strong […]
last updated on 17 Dec 07:56